Civil society groups are concerned that a ‘meaningful’ consultation process has not yet taken place despite the delay in submission of the updated NDC to the United NationsCivil society groups are concerned that a ‘meaningful’ consultation process has not yet taken place despite the delay in submission of the updated NDC to the United Nations

Corruption a threat to Philippines’ higher climate ambition – groups

2025/12/04 11:45

MANILA, Philippines – As the Philippine government proposes higher climate targets, groups warn that corruption can threaten the country’s capacity to implement programs needed to reduce greenhouse gas emissions.

The Philippines is proposing an unconditional target of between 10% to 20% — much higher than the 2.71% stated in the country’s current Nationally Determined Contribution (NDC).

The new target was presented to civil society groups on Wednesday, December 3, in a high-level plenary session. Even before the annual climate talks in Brazil took place, groups Rappler talked to had already complained about the lack of consultations on the new NDC.

“With a likely higher cost of implementation for the updated NDC to match the higher ambition, there is simply no room for any errors, especially those caused by corruption or inaction,” Aksyon Klima Pilipinas national coordinator John Leo Algo said in a statement Wednesday.

Countries like the Philippines that are party to the Paris Agreement are required to submit NDCs, or pledges on reducing greenhouse gas emissions. Back in 2021, the Philippines pledged to reduce carbon emissions by 75% — 2.71% is unconditional and 72.29% is conditional. Parties are supposed to submit to the United Nations their revised targets early 2025.

Raising unconditional targets would mean mobilizing more national resources. Conditional targets, meanwhile, are reliant on the support that the Philippines will get from the international community.

“Any commitment like the NDC is only as good as its implementation,” said Algo.

Despite the Philippines’ delayed timeline in submission, think-tank Center for Energy, Ecology, and Development (CEED) said the government has not made use of the time to have a “meaningful” consultation process. CEED was one of the groups present at the consultation arranged by the Philippine government on Wednesday.

CEED is concerned that the 2025 NDC is slated for submission to the Office of the President by December without providing civil society the full draft as well as the analyses behind the new targets.

“Government agencies must be transparent and genuinely inclusive if we are to have an NDC that is truly backed by the people,” said CEED deputy executive director Avril de Torres.

AKP pointed out that the government agencies making the 2025 NDC cannot expect “meaningful feedback” if they are not given enough time to examine the new pledges.

The Department of Environment and Natural Resources and the Climate Change Commission lead this process while the Department of Economy, Planning, and Development and the Department of Finance act as oversight agencies.

“In this regard, the government comes up short in ensuring an inclusive, bottom-up approach to this crucial part of finalizing the NDC,” Algo said.

So far, 122 parties have submitted their new NDCs to the United Nations. Parties are supposed to submit a revised NDC every five years, showing a progression in climate ambition. – Rappler.com

Market Opportunity
Notcoin Logo
Notcoin Price(NOT)
$0.000554
$0.000554$0.000554
+3.41%
USD
Notcoin (NOT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26